Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01728
|
|||||
| Drug Name |
Anisodine
|
|||||
| Synonyms |
anisodine; 52646-92-1; UNII-Z75256J75J; Z75256J75J; [(1S,2S,4R,5R)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-2,3-dihydroxy-2-phenylpropanoate; Benzeneacetic acid, alpha-hydroxy-alpha-(hydroxymethyl)-, 9-methyl-3-oxa-9-azatricyclo(3.3.1.02,4)non-7-yl ester, (7(S)-(1alpha,2beta,4beta,5alpha,7beta))-; DATURAMINE; ANISODINE [WHO-DD]; CHEMBL5095784; .ALPHA.-HYDROXYSCOPOLAMINE; DTXSID20967080; LS-28829; 6.BETA.,7.BETA.-EPOXY-1.ALPHA.H,5.ALPHA.H-TROPAN-3.ALPHA.-YL (-)-2,3-DIHYDROXY-2-PHENYLPROPIONATE; BENZENEACETIC ACID, .ALPHA.-HYDROXY-.ALPHA.-(HYDROXYMETHYL)-, 9-METHYL-3-OXA-9-AZATRICYCLO(3.3.1.02,4)NON-7-YL ESTER, (7(S)-(1.ALPHA.,2.BETA.,4.BETA.,5.ALPHA.,7.BETA.))-
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Migraine [ICD11: 8A80] | Phase 3 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C17H21NO5
|
|||||
| Canonical SMILES |
CN1C2CC(CC1C3C2O3)OC(=O)C(CO)(C4=CC=CC=C4)O
|
|||||
| InChI |
InChI=1S/C17H21NO5/c1-18-12-7-11(8-13(18)15-14(12)23-15)22-16(20)17(21,9-19)10-5-3-2-4-6-10/h2-6,11-15,19,21H,7-9H2,1H3/t11?,12-,13+,14-,15+,17-/m1/s1
|
|||||
| InChIKey |
JEJREKXHLFEVHN-QDXGGTILSA-N
|
|||||
| CAS Number |
CAS 52646-92-1
|
|||||
| Pharmaceutical Properties | Molecular Weight | 319.4 | Topological Polar Surface Area | 82.5 | ||
| Heavy Atom Count | 23 | Rotatable Bond Count | 5 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
0.6
|
|||||
| PubChem CID | ||||||
| DT(s) Transporting This Drug | OCT-2 | Transporter Info | Organic cation transporter 2 | Substrate | [2] | |
| Drug-Transporter Activity Data | ||||||
| Drug-Transporter Activity Data | OCT-2 | Transporter Info | Km = 13.3 microM | Human embryonic kidney cells (HEK293)-OCT2 | [2] | |
| References | ||||||
| 1 | ClinicalTrials.gov (NCT05416476) Anisodine Hydrobromide For The Preventive Treatment Of Episodic Migraine (ATEM). | |||||
| 2 | An in vitro study on interaction of anisodine and monocrotaline with organic cation transporters of the SLC22 and SLC47 families. Chin J Nat Med. 2019 Jul;17(7):490-497. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.